Back

Prognostic impact of disproportionate secondary tricuspid regurgitation

12 May 2023 (11:08 - 11:17)
Organised by:
Congress Presentation Part of: Optimize your understanding of valvular disease in the era of transcatheter interventions Valvular Heart Disease EACVI Premium Access EACVI 2023

About the speaker

Photo
Doctor Michele Tomaselli

Italian Auxological Institute San Luca Hospital, Milan (Italy)

6 More presentations in this session

Presentation thumbnail
Global myocardial ischaemia in severe aortic stenosis reverses early after aortic valve replacement.
Doctor G. Thornton (London, GB)
Abstract Slides Video
Presentation thumbnail
The prognostic value of low-flow in severe aortic stenosis patients undergoing TAVI - should we follow the flow?
Mr D. Santos Ferreira (Vila Nova de Gaia, PT)
Abstract Slides Video
Presentation thumbnail
Determinants of disproportionate functional mitral regurgitation
Doctor Y. arao (Ogaki, JP)
Abstract Slides Video
Presentation thumbnail
Early evolution of cardiac damage staging following transcatheter aortic valve replacement: prevalence, clinical patterns and prognostic significance
Doctor L. Scudeler (Turin, IT)
Abstract Slides Video
Presentation thumbnail
Validation of a three-dimensional trans-esophageal echocardiography analysis software to assess mitral valve annulus and predicted Neo-LVOT before trans-catheter mitral valve replacement
Doctor H. Mahmoud-Elsayed (Aswan, EG)
Abstract Slides Video

Access the full session

Session thumbnail
Optimize your understanding of valvular disease in the era of transcatheter interventions
Video

The Event

Event poster

EACVI 2023

12 May 2023 11:08 CET
You may be interested in
thumbnail
Congress Session
Focus on tricuspid regurgitation!
thumbnail
Congress Presentation
Refining the assessment of moderate secondary tricuspid regurgitation: an echocardiographic approach to risk stratification
thumbnail
Congress Presentation
Assessment and grading of tricuspid regurgitation severity

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources